Daniel Handley
Director/Board Member chez PREDICTIVE ONCOLOGY INC.
Fortune : 47 586 $ au 31/03/2024
Profil
Daniel E.
Handley is currently the Director at Translational Genomics Research Institute since 2019.
He is also an Independent Director at Predictive Oncology, Inc. since 2020 and a Professor at Southern California University of Health Sciences since 2019.
Previously, he worked as a Laboratory Manager at David Geffen School of Medicine from 1991 to 1994.
He also served as the Chief Scientific Officer at Life-SEQ LLC and Advanced Healthcare Technology Solutions, Inc. from 2010 to 2013.
Dr. Handley holds a graduate degree from Carnegie Mellon University, a doctorate from the University of Pittsburgh, and an undergraduate degree from The Johns Hopkins University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PREDICTIVE ONCOLOGY INC
0,46% | 05/04/2024 | 18 661 ( 0,46% ) | 47 586 $ | 31/03/2024 |
Postes actifs de Daniel Handley
| Sociétés | Poste | Début |
|---|---|---|
| PREDICTIVE ONCOLOGY INC. | Director/Board Member | 19/02/2020 |
| Southern California University of Health Sciences | Corporate Officer/Principal | 01/04/2019 |
Translational Genomics Research Institute
 Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Director/Board Member | 01/04/2019 |
Anciens postes connus de Daniel Handley
| Sociétés | Poste | Fin |
|---|---|---|
| Advanced Healthcare Technology Solutions, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| David Geffen School of Medicine | Corporate Officer/Principal | 01/01/1994 |
Life-SEQ LLC
 Life-SEQ LLC Miscellaneous Commercial ServicesCommercial Services Life-SEQ LLC provides health care professional training, logistics, consulting, and telemedicine support services. The private company is based in Boston, MA. The company was founded by Timothy Adam Krochuk and Gregory S. St. Clair. | Chief Tech/Sci/R&D Officer | - |
Formation de Daniel Handley
| Carnegie Mellon University | Graduate Degree |
| University of Pittsburgh | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Translational Genomics Research Institute
Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Commercial Services |
Life-SEQ LLC
Life-SEQ LLC Miscellaneous Commercial ServicesCommercial Services Life-SEQ LLC provides health care professional training, logistics, consulting, and telemedicine support services. The private company is based in Boston, MA. The company was founded by Timothy Adam Krochuk and Gregory S. St. Clair. | Commercial Services |
| Advanced Healthcare Technology Solutions, Inc. |
